Available IPD datapackage for study 'Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection Who Are at Increased Risk of Recurrence'

REMICADE (infliximab) is a drug used to treat active Crohn's disease and is being tested in an experiment to see if it may be useful in preventing relapse of Crohn's disease after surgical resection. This study will compare the effects (both good and bad) of REMICADE (infliximab) to those of placebo. Placebo looks like the drug being studied but has no active ingredients.

英夫利昔单抗（infliximab，商品名REMICADE）是一款用于治疗活动性克罗恩病的药物，目前正处于一项临床试验阶段，以评估其在克罗恩病手术切除后预防疾病复发的潜在效用。本研究将对比英夫利昔单抗与安慰剂的效应（包括有益与不良反应）。安慰剂外观与受试药物一致，但不含任何活性成分。